These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8542898

  • 1. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging.
    Huitink JM, Visser FC, van Leeuwen GR, van Lingen A, Bax JJ, Heine RJ, Teule GJ, Visser CA.
    Eur J Nucl Med; 1995 Oct; 22(10):1141-8. PubMed ID: 8542898
    [Abstract] [Full Text] [Related]

  • 2. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
    Bax JJ, Veening MA, Visser FC, van Lingen A, Heine RJ, Cornel JH, Visser CA.
    Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874
    [Abstract] [Full Text] [Related]

  • 3. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
    Bax JJ, Visser FC, Raymakers PG, Van Lingen A, Cornel JH, Huitink JM, Elhendy A, Heine RJ, Visser CA.
    Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
    [Abstract] [Full Text] [Related]

  • 4. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
    Bax JJ, Visser FC, Poldermans D, van Lingen A, Elhendy A, Boersma E, Visser CA.
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):452-7. PubMed ID: 11914881
    [Abstract] [Full Text] [Related]

  • 5. Planar cardiac F-18 fluorodeoxyglucose imaging with a conventional gamma camera.
    Kalff V, Van Every B, Lambrecht RM, Rowe JL, Barton HJ, Leaney P, Jamieson CR, Kelly MJ.
    Med J Aust; 1994 Oct 03; 161(7):413-7. PubMed ID: 7935094
    [Abstract] [Full Text] [Related]

  • 6. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
    Kalff V, Berlangieri SU, Van Every B, Rowe JL, Lambrecht RM, Tochon-Danguy HJ, Egan GF, McKay WJ, Kelly MJ.
    Eur J Nucl Med; 1995 Jul 03; 22(7):625-32. PubMed ID: 7498223
    [Abstract] [Full Text] [Related]

  • 7. Course of impaired left ventricular function after acute myocardial infarction predicted with planar thallium-201 chloride and F18-fluorodeoxyglucose imaging.
    Huitink JM, Visser FC, Bax JJ, van Lingen A, Visser CA.
    Int J Cardiol; 1996 Dec 13; 57(3):271-81. PubMed ID: 9024916
    [Abstract] [Full Text] [Related]

  • 8. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia.
    Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Aoyagi T, Sugiura S, Yamada N, Ohtomo K, Sasaki Y, Omata M, Yazaki Y.
    J Nucl Med; 1999 Jul 13; 40(7):1116-21. PubMed ID: 10405129
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ, Yki-Järvinen H, Voipio-Pulkki LM, Mäki M, Ruotsalainen U, Härkönen R, Teräs M, Haaparanta M, Bergman J, Hartiala J, Wegelius U, Nuutila P.
    J Nucl Med; 1994 Jun 13; 35(6):989-98. PubMed ID: 8195886
    [Abstract] [Full Text] [Related]

  • 12. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL.
    Circulation; 1991 Jan 13; 83(1):26-37. PubMed ID: 1984883
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Re-evaluation of myocardial FDG uptake in hyperglycemia.
    Kubota K, Kubota R, Yamada S, Tada M, Takahashi T, Iwata R.
    J Nucl Med; 1996 Oct 13; 37(10):1713-7. PubMed ID: 8862317
    [Abstract] [Full Text] [Related]

  • 15. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
    Tamaki N, Yonekura Y, Kawamoto M, Magata Y, Sasayama S, Takahashi N, Nohara R, Kambara H, Kawai C, Konishi J.
    J Nucl Med; 1991 Nov 13; 32(11):2152-7. PubMed ID: 1941154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals.
    Bax JJ, Visser FC, van Lingen A, Groeneveld AB, Huitink JM, Teule GJ, Visser CA.
    Eur J Nucl Med; 1995 Jan 13; 22(1):56-60. PubMed ID: 7698156
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantitative planar imaging of glucose metabolic activity in myocardial segments with exercise thallium-201 perfusion defects in patients with myocardial infarction: comparison with late (24-hour) redistribution thallium imaging for detection of reversible ischemia.
    Williams KA, Taillon LA, Stark VJ.
    Am Heart J; 1992 Aug 13; 124(2):294-304. PubMed ID: 1636573
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
    Choi Y, Brunken RC, Hawkins RA, Huang SC, Buxton DB, Hoh CK, Phelps ME, Schelbert HR.
    Eur J Nucl Med; 1993 Apr 13; 20(4):308-18. PubMed ID: 8491223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.